跳至主要内容
临床试验/NCT00382135
NCT00382135已完成4 期

An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil

Eli Lilly and Company1 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2003年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
282
试验地点
1
主要终点
Change in sperm production measured at baseline and after 9 months of treatment.

研究概览

简要总结

This is a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel design study to evaluate effects on semen characteristics after 40 weeks of daily dosing with 20 mg tadalafil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male subjects or men with mild erectile dysfunction
  • At least 45 years of age
  • With specified semen characteristics.

排除标准

  • Certain chronic medical conditions including cardiac disease, congestive heart failure, kidney or liver disease, cancer and HIV
  • A history of certain endocrine or hormonal abnormalities
  • A history of significant testicular/genital abnormalities
  • Any significant reproductive abnormality identified at the start of the study.

研究组 & 干预措施

1

Placebo Comparator

placebo tablet

干预措施: placebo (Drug)

2

Active Comparator

20 mg tadalafil tablet

干预措施: tadalafil (Drug)

结局指标

主要结局

Change in sperm production measured at baseline and after 9 months of treatment.

时间窗: 40 weeks

次要结局

  • Changes in other semen characteristics and reproductive hormones.(40 weeks)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验